Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM).
- Fonction : Auteur
- PersonId : 169595
- IdHAL : nadine-bossard
- IdRef : 077465946
- Fonction : Auteur
- PersonId : 734937
- IdHAL : laurent-remontet
- ORCID : 0000-0003-3393-4216
- IdRef : 240833201
- Fonction : Auteur
- PersonId : 906758
- ORCID : 0000-0001-9070-1027
- Fonction : Auteur
- PersonId : 949313
- ORCID : 0000-0002-4891-9628
- Fonction : Auteur
- PersonId : 949314
- ORCID : 0000-0001-8509-949X
- Fonction : Auteur
- PersonId : 863704
- IdHAL : guy-launoy
- ORCID : 0000-0002-7052-0242
- Fonction : Auteur
- PersonId : 854904
- ORCID : 0000-0003-0669-2274
- Fonction : Auteur
- PersonId : 946151
- ORCID : 0000-0002-6755-5970
- IdRef : 061581704
- Fonction : Auteur
- PersonId : 906757
- IdRef : 236531611
Résumé
We present the main results of the first population-based cancers survival study gathering all French registry data. Survival data on 205,562 cancer cases diagnosed between 01/01/1989 and 31/12/1997 were analysed. Relative survival was estimated using an excess rate model. The evolution of the excess mortality rate over the follow-up period was graphed. The analysis emphasised the effect of age at diagnosis and its variation with time after diagnosis. For breast and prostate cancers, the age-standardised five-year relative survivals were 84% and 77%, respectively. The corresponding results in men and women were 56% versus 58% for colorectal cancer and 12% versus 16% for lung cancer. For some cancer sites, the excess mortality rate decreased to low values by five years after diagnosis. For most cancer sites, age at diagnosis was a negative prognostic factor but this effect was often limited to the first year after diagnosis.